Gianluca Pettiti, Executive Vice President of Thermo Fisher Scientific Inc.'s (TMO) Life Sciences Solutions branch, sold 400 shares of the company's stock on February 9, 2026. This transaction continues a pattern of insider selling by Pettiti, who has divested a total of 4,875 shares over the past year without any corresponding purchases. Thermo Fisher Scientific is currently considered fairly valued, trading at $541.2 against a GuruFocus Value of $573.09. The company boasts a substantial market capitalization exceeding $198 billion, underscoring its significant market presence. While insider selling can sometimes signal a lack of confidence, the quantity of shares sold is relatively small compared to the firm's vast market cap. This suggests a potentially minor market impact, or it could be attributed to personal financial considerations for the executive.
Get AI-powered deep analysis for every story with a paid subscription
Upgrade for Analysis